eEF2K is a poor prognostic factor and novel molecular target in pancreatic cancer: regulating tumor growth and progression via the tumor microenvironment
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1038/s41419-025-07803-w
dc.identifier.other
WOS:001524040400004
dc.description.volume
dc.description.issue
Publisher
SPRINGERNATURE
DOI
10.1038/s41419-025-07803-w
